Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

RNA Sequencing Services Market Forecast Highlighting Growth From $4.43 Billion To $6.37 Billion

The RNA sequencing services sector is experiencing significant expansion. Its market value is projected to increase from $3.99 billion in 2025 to $4.44 billion in 2026, reflecting a compound annual growth rate of 11.2%. This robust growth observed previously was fueled by several key factors including amplified investments in genomic research, the broadening scope of academic and governmental research programs, a greater adoption of sequencing for fundamental biological investigations, the decreasing expense associated with sequencing technologies, and a wider accessibility of companies offering sequencing services.

The RNA sequencing services market is poised for significant expansion in the upcoming years, projecting a rise to $6.38 billion by 2030, fueled by a compound annual growth rate (CAGR) of 9.5%. This anticipated growth trajectory is underpinned by several key drivers, including the escalating embrace of precision medicine strategies, a burgeoning need for transcriptomic data in diagnostic applications, intensified research and development efforts within the pharmaceutical sector, the increasing incorporation of AI-powered data analytics, and a growing trend towards outsourcing sequencing services. Furthermore, several prominent trends are expected to shape the market during this forecast period, such as a heightened demand for high-throughput transcriptomic analysis, the wider adoption of next-generation sequencing (NGS)-based RNA sequencing, a broader offering of sequencing services integrated with bioinformatics capabilities, increased utilization of RNA sequencing in clinical research endeavors, and a heightened emphasis on ensuring data precision and consistent results.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

RNA Sequencing Services Market Expansion Drivers: What Is Shaping Future Growth?

The increasing need for tailored medical interventions, known as personalized medicine, is a key factor propelling the expansion of the RNA sequencing services market. Personalized medicine involves customizing treatments based on an individual’s unique genetic makeup, lifestyle, and other factors to achieve greater efficacy and fewer side effects. This approach is gaining traction due to its promise of superior treatment outcomes, breakthroughs in genomic research, the rising intricacy of diseases, and supportive regulatory frameworks. RNA sequencing services play a crucial role in this field by enabling the identification of distinct disease subtypes, the discovery of relevant biomarkers, the pinpointing of therapeutic targets, the prediction of patient responses to treatments, and the monitoring of disease progression and therapeutic impact. By leveraging RNA sequencing technology, personalized medicine strategies can deliver highly individualized and effective remedies that precisely address the specific molecular profiles of each patient. Illustratively, data from the Personalized Medicine Coalition indicated that in February 2024, the US FDA authorized sixteen new personalized therapies for individuals suffering from rare diseases during 2023, a notable increase from the six approvals seen in 2022. Among these 2023 approvals were seven new cancer medications and three for various other ailments and conditions. Consequently, the escalating demand for personalized medicine is anticipated to continue driving the growth trajectory of the RNA sequencing services market.

RNA Sequencing Services Market Segment Landscape And Growth Potential

The rna sequencing services market covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods

3) By Application Area: Research Purposes, Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

RNA Sequencing Services Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Companies prominent in the RNA sequencing services sector are prioritizing automated processes to minimize inaccuracies stemming from human interaction, exemplified by the next-generation sequencing (NGS) assay, with the objective of boosting both the efficiency and precision of data output and interpretation. The RNA next-generation sequencing (RNA-seq) assay stands as a vital instrument within molecular biology and genomics for scrutinizing the complete set of RNA molecules (transcriptome) present in a biological specimen. To illustrate, in June of 2023, Tempus, a technology firm specializing in precision medicine based in the United States, introduced its novel, standalone RNA next-generation sequencing assay, branded as Tempus xR. This cutting-edge assay, developed for the analysis of solid tumors, facilitates an exhaustive examination of the entire transcriptome, pinpointing clinically relevant gene fusions across more than 100 genes of interest, in addition to detecting aberrant splicing patterns in MET Exon 14 and EGFRvIII. Acknowledging the critical importance of RNA sequencing information, Tempus has consistently integrated both RNA and DNA sequencing into its standard broad-panel xT assay. Currently, customers possess the flexibility to request each test independently or concurrently, with the additional choice of augmenting the xR assay with select algorithmic tests from Tempus. This service provides a tailored solution for clinicians particularly interested in RNA fusions or splicing alterations, as well as for healthcare providers, scientific investigators, and pharmaceutical enterprises desiring in-depth RNA sequencing analysis of their existing sample collections.

RNA Sequencing Services Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the rna sequencing services market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen NV, BGI Genomics Co Ltd, Azenta Inc., Novogene Co Ltd, Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, Genomax Technologies Pte Ltd, Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics, Novaseq Services Ltd

Access The Complete RNA Sequencing Services Market Report:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

RNA Sequencing Services Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the RNA sequencing services market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the rna sequencing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model